Background Sphingosine-one phosphate receptor (S1PR) modulation inhibits S1PR1-
mediated lymphocyte migration, lesion formation and positively-impacts on active multiple …

The standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses
administered three weeks apart. However, some public health authorities spaced these …

Molecular mimicry between viral antigens and host proteins can produce cross-reacting
antibodies leading to autoimmunity. The coronavirus SARS-CoV-2 causes COVID-19, a …

Background The global pandemic of coronavirus disease 2019 (COVID-19) is caused by
infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus (SARS-CoV-2), has affected all countries worldwide. Although some …

SARS-CoV-2 is a novel betacoronavirus that caused coronavirus disease 2019 and has
resulted in millions of deaths worldwide. Novel coronavirus infections in humans have …

Susceptibility and severity of COVID-19 infection vary widely. Prior exposure to endemic
coronaviruses, common in young children, may protect against SARS-CoV-2. We evaluated …

Existing assays to measure antibody cross-reactivity against different SARS-CoV-2 spike (S)
protein variants lack the discriminatory power to provide insights at the level of individual …

From the beginning of the COVID-19 pandemic, children have exhibited different
susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

The origins of preexisting SARS-CoV-2 cross-reactive antibodies and their potential impacts
on vaccine efficacy have not been fully clarified. In this study, we demonstrated that S2 was …